Table 3 Changes of panic symptoms across the treatment, including effect sizes

ACQ^c

22.9(4.7)

27.7(5.0)

.<000

-2.34

30.8(8.8)

20.7(6.1)

<0.00

1.59

PDSS^d-total

11.1(4.1)

9.1(4.4)

.047

0.62

13.2(4.7)

5.9(4.3)

<0.00

1.41

PDSS^d-item

<0.00

frequency of panic

1.1(0.5)

0.9(0.5)

.317

0.30

1.3(0.9)

0.8(0.8)

<0.00

0.56

distress duringpanic

2.4(1.1)

2.4(1.1)

.732

0.03

2.5(1.4)

1.4(1.1)

<0.00

0.70

anticipatory anxiety

1.2(1.1)

1.1(0.6)

.792

0.08

1.9(1.0)

0.8(0.8)

<0.00

1.01

agoraphobic fear/avoidance

2.0(1.0)

1.5(0.8)

.107

0.53

2.2(1.1)

0.9(0.9)

<0.00

1.08

interoceptive fear/avoidance

0.6(0.8)

0.7(0.9)

.603

-0.15

1.2(1.1)

0.5(0.8)

<0.00

0.60

impairment of work functioning

1.8(1.2)

1.5(1.3)

.206

0.39

2.1(1.2)

0.7(1.2)

<0.00

1.03

impairment of social functioning

2.0(1.0)

1.1(1.1)

.039

0.74

2.1(1.1)

0.9(1.0)

<0.00

1.08

FQ-ag^e

13.6(12.2)

10.6(8.2)

.153

0.42

13.2(9.8)

5.1(6.4)

<0.00

0.79

MI-alone^f

2.4(0.9)

2.1(0.7)

.070

0.61

2.6(1.0)

1.7(0.7)

<0.00

1.59

WHLS ^g

3.2(2.1)

2.4(1.8)

.026

0.78

2.7(1.4)

1.3(1.3)

<0.00

0.53